Skip to main content
. 2016 Jul 18;11(7):e0158526. doi: 10.1371/journal.pone.0158526

Fig 2. SVR4 and SVR12 rates for all patients, patients receiving 12 weeks of treatment, and patients receiving >12 weeks of treatment.

Fig 2